NUCLEOME THERAPEUTICS
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 95% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. We have the unique ability to link these variants to gene function and map disease pathways. Our cell type-specific platform creates high resolution 3D genome structure maps and enables variant functional validatio... n at scale in primary cell types. This enables us to discover and develop novel, better and safer drugs. The initial focus of the company is on lymphocytes and related autoimmune disease. Our ambition is to build a robust pipeline of drug assets, with corresponding biomarkers. Nucleome Therapeutics was founded by leading experts in gene regulation from the University of Oxford and backed by investment from Oxford Sciences Innovation. For more information, please visit www.nucleome.com.
NUCLEOME THERAPEUTICS
Industry:
Biotechnology Genetics Therapeutics
Founded:
2019-01-01
Address:
Headington, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.nucleome.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Organization Schema
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Encoded Therapeutics
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Xenothera
Xenothera is a xenotherapy platform with embedded technology that renovates immunological treatments.
Current Employees Featured
Founder
Investors List
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Nucleome Therapeutics
Official Site Inspections
http://www.nucleome.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 119.0.153.160.host.secureserver.net
- IP address: 160.153.0.119
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
